![Norbert Oppitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norbert Oppitz
Corporate Officer/Principal at
SWEDISH ORPHAN BIOVITRUM AB
Net worth: 4 M $ as of 30/05/2026
Profile
Norbert Oppitz is currently the Head-International at Swedish Orphan Biovitrum AB. Previously, he worked as the Head-Latin America at Nycomed AB.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 86,954 ( 0.02% ) | 4 M $ | 30/05/2026 |
Norbert Oppitz active positions
| Companies | Position | Start |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/10/2017 |
Former positions of Norbert Oppitz
| Companies | Position | End |
|---|---|---|
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
- Stock Market
- Insiders
- Norbert Oppitz
